ArticleTherapeutic advances in psychopharmacology2015

A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia.

Steven G Potkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.